Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally. It operates in the field of computer assisted surgery that enable the use of surgical instruments with high precision and minimal invasiveness and that simplifies complex surgical procedures. The company's surgical robotic-guidance systems and complementary products are used to conduct spine and brain procedures in an accurate and secure manner. It also offers Mazor X, a renaissance system and its accessories are used in spine surgeries, including fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. The company was formerly known as Mazor Surgical Technologies Ltd. and changed its name to Mazor Robotics Ltd. in 2010. Mazor Robotics Ltd. was founded in 2000 and is based in Caesarea, Israel.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone972-4618-7101
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$64.95 million
Profitability
Miscellaneous
Employees194
OptionableOptionable
Mazor Robotics (NASDAQ:MZOR) Frequently Asked Questions
What is Mazor Robotics' stock symbol?
Mazor Robotics trades on the NASDAQ under the ticker symbol "MZOR."
How were Mazor Robotics' earnings last quarter?
Mazor Robotics Ltd - (NASDAQ:MZOR) announced its quarterly earnings data on Thursday, August, 2nd. The medical instruments supplier reported ($0.14) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.01) by $0.13. The medical instruments supplier earned $13.20 million during the quarter, compared to analysts' expectations of $17.02 million. Mazor Robotics had a negative net margin of 37.29% and a negative return on equity of 7.70%. The business's revenue for the quarter was down 14.8% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.05) earnings per share. View Mazor Robotics' Earnings History.
What price target have analysts set for MZOR?
3 brokers have issued 12 month price targets for Mazor Robotics' stock. Their predictions range from $57.00 to $62.00. On average, they expect Mazor Robotics' share price to reach $59.50 in the next twelve months. View Analyst Price Targets for Mazor Robotics.
What is the consensus analysts' recommendation for Mazor Robotics?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mazor Robotics in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Mazor Robotics.
What are Wall Street analysts saying about Mazor Robotics stock?
Here are some recent quotes from research analysts about Mazor Robotics stock:
- 1. According to Zacks Investment Research, "Mazor Robotics Ltd. is engaged in the development, production and marketing of medical devices for surgical procedures in the fields of orthopedics and neurosurgery. It offers Renaissance(TM), a surgical robotic system to conduct spine surgeries with less radiation. The company operates in the United States, Eastern Europe, Western Europe and Asia. Mazor Robotics Ltd. is based in Caesarea, Israel. " (11/15/2018)
- 2. Needham & Company LLC analysts commented, "MZOR reported revenue and EPS that were below consensus. On 11/19/18, MZOR will hold a shareholder vote to confirm MDT’s proposed acquisition. We see no reason to believe the deal will not be confirmed and we maintain our Hold rating." (11/7/2018)
Has Mazor Robotics been receiving favorable news coverage?
News articles about MZOR stock have been trending somewhat negative on Wednesday, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Mazor Robotics earned a news impact score of -1.0 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 4.0 out of 10, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
Who are some of Mazor Robotics' key competitors?
Some companies that are related to Mazor Robotics include Insulet (PODD), Penumbra (PEN), ICU Medical (ICUI), Novocure (NVCR), Globus Medical (GMED), Haemonetics (HAE), Integra Lifesciences (IART), Cantel Medical (CMD), Merit Medical Systems (MMSI), NuVasive (NUVA), Tandem Diabetes Care (TNDM), Glaukos (GKOS), Irhythm Technologies (IRTC), Atrion (ATRI) and Nevro (NVRO).
Who are Mazor Robotics' key executives?
Mazor Robotics' management team includes the folowing people:
- Mr. Ori Hadomi, CEO & Director (Age 51)
- Mr. Eliyahu Zehavi, Co-Founder & Exec. VP of Advanced Technologies (Age 63)
- Ms. Sharon Levita, CFO, VP of Bus. Operations & Company Sec. (Age 51)
- Dr. Doron Dinstein M.D., Chief Medical Officer (Age 47)
- Mr. Christopher Prentice, Chief Commercial Officer (Age 48)
How do I buy shares of Mazor Robotics?
Shares of MZOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How big of a company is Mazor Robotics?
Mazor Robotics has a market capitalization of $0.00 and generates $64.95 million in revenue each year. The medical instruments supplier earns $-12,410,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Mazor Robotics employs 194 workers across the globe.
What is Mazor Robotics' official website?
How can I contact Mazor Robotics?
Mazor Robotics' mailing address is 5 SHACHAM STREET NORTH INDUSTRIAL PARK, CAESAREA L3, 3088900. The medical instruments supplier can be reached via phone at 972-4618-7101 or via email at [email protected]
MarketBeat Community Rating for Mazor Robotics (NASDAQ MZOR)
MarketBeat's community ratings are surveys of what our community members think about Mazor Robotics and other stocks. Vote "Outperform" if you believe MZOR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MZOR will underperform the S&P 500 over the long term. You may vote once every thirty days.
